News
Addressing social needs may help cancer outcomes
Identifying social needs of cancer patients and developing interventions to mitigate them could improve health outcomes. The survey-based study, published in Cancer (12 July), found unmet social needs in gynaecological cancers were associated with emergency room visits, hospital admissions and…
Aspirin cuts risk of death from a wide range of cancers
Taking aspirin together with cancer treatment results in reductions in death from cancer and all-cause mortality, both by around one fifth. The meta-analysis, published in ecancermedicalscience, (online 2 July), demonstrates benefits for aspirin across a range of cancers and shows…
Heart failure may be oncogenic, statins could reduce cancer risk
Two studies highlight the relationship between heart failure and cancer, showing people with heart failure are more likely to develop cancer, and that statins may reduce that risk. The first study, published in ESC Heart Failure (28 June 2021), found heart failure…
Cancer trials interruption in Latin America halts treatment for many
The interruption of cancer clinical trials across Latin America due to the COVID-19 pandemic is threatening the treatment of thousands of patients in the public health system. A JCO Global Oncology study, conducted by the Latin American Cooperative Oncology Group…
ACE inhibitor protects against cardiotoxicity
In HER2 breast cancer, concurrent use of the ACE inhibitor lisinopril with trastuzumab-anthracyclines benefits left ventricular ejection fraction (LVEF). The study, abstract 509, presented in a poster session at the ASCO meeting, June 4-8, found breast cancer patients treated with…
Advance Care Planning increases hope
Hope for cancer patients may be increased by engaging in advanced care planning (ACP). The study, abstract 12029, presented in a poster session at ASCO, which took place online June 4-8, found that hope was significantly higher among patients who…
Wake-up call to offer equal access to life-prolonging treatments in metastatic prostate cancer
Less than one third of men with metastatic castration-sensitive prostate cancer (mCSPC) received established treatment intensification by 2018 that had been demonstrated to extend survival. The US study evaluating real-world utilization of advanced therapies, abstract 5073, released in advance of…
Study provides motivation for European policy makers to implement comprehensive tobacco control
Fully implementing tobacco control policies across Europe would avoid an estimated 1.65 million lung cancer cases over the next 20 years. The modelling study, published in the May issue of The Lancet Regional Health-Europe, found the largest proportion of lung…
Fit, susceptible, or frail? Updated recommendations for managing breast cancer in older people
Management of breast cancer in older women should include routine use of geriatric assessments. Recommendations from an updated multidisciplinary taskforce, which includes members of the European Society of Breast Cancer Specialists and International Society of Geriatric Oncology, published in Lancet…
Ovarian cancer population screening study signals need for additional biomarkers
Annual screening for ovarian cancer detects cancer earlier but does not save lives, concludes the largest ovarian cancer screening trial up to now. On the basis of the UK study, published in The Lancet (13th May 2021), general population screening…